ALBO Chart
- 52-Week Range: $21.16 - $37.29
- Market Capitalization: $412.07M
- Short Percentage: 0%
- Target Price: $70.40
- Shares Outstanding: 19.57M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ALBO released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
- Albireo Reports Q4 and Year-End 2021 Financial Results and Business UpdateGlobeNewsWire | March 1st
- Adult Liver Diseases: The R&D Engine Drives Albireo's Long-Term Prospects.Seeking Alpha | February 1st
- Albireo: Successful And Accelerating Global Launch Drives Sales RevenueSeeking Alpha | January 31st
- Albireo Announces Positive Topline Data from Phase 1 Study of A3907GlobeNewsWire | December 16th
- Albireo Expands Leadership with Constantine Chinoporos as Chief Business OfficerGlobeNewsWire | December 2nd
- Albireo: Reasons For A Successful Transformation Into A Commercial CompanySeeking Alpha | November 24th
- Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 4th
Company Info
Website: https://www.albireopharma.com
Address: 10 Post Office Square, Boston, MA, United States, 02109
Sector: Healthcare
Industry: Biotechnology
Full time employees: 130
Address: 10 Post Office Square, Boston, MA, United States, 02109
Sector: Healthcare
Industry: Biotechnology
Full time employees: 130
$ALBO Looks like a solid reversal - retesting support right now
definitely thinking about swinging this
$ALBO bounce back baby
$ALBO call the SEC
$ALBO news?
$ALBO holding and buying these dips is so easy.
$ALBO Nothing but time to wait
$ALBO i am trading for a better future!
$ALBO Mindset is key
$ALBO i hate money so im buying
$ALBO The best investment you can make is an investment in yourself or another person